AbbVie Short Interest Ratio and Short Volume

+0.56 (+0.52 %)
(As of 09/16/2021 03:11 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume298,003 shs
Average Volume7.02 million shs
Market Capitalization$191.44 billion
P/E Ratio29.20
Dividend Yield4.88%

AbbVie (NYSE:ABBV) Short Interest Data

Current Short Volume13,550,000 shares
Previous Short Volume13,090,000 shares
Change Vs. Previous Month+3.51%
Dollar Volume Sold Short$1.64 billion
Short Interest Ratio / Days to Cover2.0
Last Record DateAugust, 31 2021
Outstanding Shares1,767,176,000 shares
Float Size1,760,000,000 shares
Short Percent of Float0.77%
Today's Trading Volume298,003 shares
Average Trading Volume7,023,322 shares
Today's Volume Vs. Average-95.76%

Short Interest Over Time

Days to Cover Over Time

Percentage of Float Shorted Over Time

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling AbbVie ?

Sign up to receive the latest short interest report for AbbVie and its competitors with MarketBeat's FREE newsletter.

AbbVie (NYSE:ABBV) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
8/31/202113,550,000 shares $1.64 billion +3.5%0.8%2 $120.78
8/13/202113,090,000 shares $1.52 billion -9.4%0.7%2.2 $116.48
7/30/202114,450,000 shares $1.68 billion -1.4%0.8%2.3 $116.30
7/15/202114,660,000 shares $1.72 billion +6.5%0.8%2.3 $117.18
6/30/202113,770,000 shares $1.55 billion +3.2%0.8%2.2 $112.64
6/15/202113,340,000 shares $1.55 billion -9.6%0.8%2 $115.83
5/28/202114,760,000 shares $1.67 billion -3.4%0.8%2.1 $113.20
5/14/202115,280,000 shares $1.78 billion +2.6%N/A2.2 $116.60
4/30/202114,890,000 shares $1.65 billion -20.4%N/A2.2 $110.89
4/15/202118,710,000 shares $1.98 billion +11.4%N/A2.6 $105.90
3/31/202116,800,000 shares $1.79 billion +3.7%N/A2.3 $106.79
3/15/202116,200,000 shares $1.75 billion +5.0%N/A2.2 $108.22
2/26/202115,430,000 shares $1.66 billion +8.1%N/A2.2 $107.33
2/12/202114,280,000 shares $1.48 billion -4.0%N/A1.9 $103.75
1/29/202114,870,000 shares $1.55 billion +18.1%N/A1.9 $104.21
1/15/202112,590,000 shares $1.41 billion -5.6%N/A1.5 $111.63
12/31/202013,330,000 shares $1.40 billion -3.8%N/A1.6 $105.27
12/15/202013,850,000 shares $1.44 billion +4.4%N/A1.7 $104.20
11/30/202013,270,000 shares $1.39 billion -5.2%N/A1.6 $104.89
11/15/202014,000,000 shares $1.39 billion +9.0%N/A1.7 $99.04
10/30/202012,840,000 shares $1.04 billion +20.7%N/A1.6 $80.67
10/15/202010,640,000 shares $915.78 million -17.8%N/A1.5 $86.07
9/30/202012,940,000 shares $1.13 billion -2.6%N/A1.9 $87.59
9/15/202013,280,000 shares $1.21 billion +9.2%N/A1.9 $90.91
8/31/202012,160,000 shares $1.16 billion -2.0%N/A1.7 $95.77

Institutional Investors Shorting AbbVie (NYSE:ABBV)

This table shows institutional investors, funds, and major shareholders that have reported short positions as of their most recent reporting period. Most commonly, these investors have purchased put options on shares of AbbVie. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Reporting DateInvestor NameShares Shorted (Previous)Shares Shorted (Current)Position ChangePosition Size
9/13/2021Bank of America Corp DE183,400614,000+234.8%$69,161.00
9/10/2021HBK Investments L P37,9000-100.0%$0.00
8/31/2021Pathstone Family Office LLCN/A19,511N/A$2,198.00
8/17/2021Wells Fargo & Company MNN/A188,000N/A$21,176.00
8/17/2021Walleye Trading LLC180,300112,500-37.6%$12,672.00
8/17/2021Logan Capital Management Inc.N/A34,632N/A$3,901.00
8/17/2021Millennium Management LLC1,692,1001,737,800+2.7%$195,746.00
8/17/2021Pathstone Family Office LLCN/A19,511N/A$2,198.00
8/17/2021Parallax Volatility Advisers L.P.190,300157,400-17.3%$17,728.00
8/17/2021Balyasny Asset Management LLCN/A7,300N/A$822.00
8/17/2021Citadel Advisors LLC1,742,3861,952,486+12.1%$219,928.00
8/16/2021Squarepoint Ops LLC136,00097,700-28.2%$11,005.00
8/16/2021Bank of America Corp DE183,400614,000+234.8%$69,161.00
8/16/2021SG3 Management LLCN/A50,900N/A$5,733.00
8/16/2021Point72 Asset Management L.P.100,0000-100.0%$0.00
8/16/2021Royal Bank of Canada300,000300,400+0.1%$33,837.00
8/16/2021Credit Suisse AG1,305,700926,400-29.0%$104,035.00
8/16/2021Maven Securities LTD13,40027,200+103.0%$3,064.00
8/16/2021HBK Investments L P37,9000-100.0%$0.00
8/16/2021Capula Management Ltd93,90040,400-57.0%$4,501.00
8/16/2021Goldman Sachs Group Inc.468,900572,700+22.1%$64,509.00
8/16/2021Allianz Asset Management GmbH48,70055,700+14.4%$6,274.00
8/13/2021PEAK6 Investments LLC162,700171,900+5.7%$19,363.00
8/13/2021Lavaca Capital LLCN/A9,800N/A$1,104.00
8/13/2021SpiderRock Advisors LLC500500No Change$32.00
8/12/2021Lido Advisors LLCN/A13,300N/A$1,498.00
8/12/2021SG Americas Securities LLC118,000118,000No Change$105.00
8/12/2021Simplex Trading LLC3,618798,300+21,964.7%$89,920.00
8/12/2021JPMorgan Chase & Co.18,100100,800+456.9%$11,354.00
8/12/2021Capital Fund Management S.A.222,10049,600-77.7%$5,587.00
8/11/2021HAP Trading LLC77,10048,000-37.7%$172.00
8/11/2021Susquehanna International Group LLP3,894,6004,730,000+21.5%$532,787.00
8/10/2021BNP Paribas Arbitrage SA8,15810,669+30.8%$120,176.00
8/10/2021Citigroup Inc.858,1001,112,200+29.6%$125,278.00
8/6/2021Wolverine Trading LLC357,600463,900+29.7%$52,096.00
8/6/2021IMC Chicago LLC131,000182,100+39.0%$20,512.00
8/6/2021Gladius Capital Management LP107,60016,300-84.9%$1,837.00
8/5/2021US Bancorp DE195-73.7%$0.00
8/2/2021Mint Tower Capital Management B.V.33,50018,800-43.9%$2,118.00
7/31/2021Clear Street Markets LLC430764+77.7%$8,606.00
7/31/2021Cutler Group LP32,600181,800+457.7%$53.00
7/26/2021XR Securities LLC11,40015,300+34.2%$56.00
7/24/2021Trinity Legacy Partners LLC1,7002,600+52.9%$3.00

AbbVie (NYSE:ABBV) Short Interest FAQ

speech bubbles
speech bubbles

What is AbbVie's current short interest?

Short interest is the volume of AbbVie shares that have been sold short but have not yet been closed out or covered. As of August 31st, investors have sold 13,550,000 shares of ABBV short. 0.77% of AbbVie's shares are currently sold short. Learn More on AbbVie's current short interest.

What is a good short interest ratio for AbbVie?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AbbVie currently has a short interest ratio of 2.0. Learn More on a good short interest ratio for AbbVie

Which institutional investors are shorting AbbVie?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of AbbVie: Bank of America Corp DE, HBK Investments L P, Pathstone Family Office LLC, Wells Fargo & Company MN, Walleye Trading LLC, Logan Capital Management Inc., Millennium Management LLC, Pathstone Family Office LLC, Parallax Volatility Advisers L.P., Balyasny Asset Management LLC, Citadel Advisors LLC, Squarepoint Ops LLC, Bank of America Corp DE, SG3 Management LLC, Point72 Asset Management L.P., Royal Bank of Canada, Credit Suisse AG, Maven Securities LTD, HBK Investments L P, Capula Management Ltd, Goldman Sachs Group Inc., Allianz Asset Management GmbH, PEAK6 Investments LLC, Lavaca Capital LLC, SpiderRock Advisors LLC, Lido Advisors LLC, SG Americas Securities LLC, Simplex Trading LLC, JPMorgan Chase & Co., Capital Fund Management S.A., HAP Trading LLC, Susquehanna International Group LLP, BNP Paribas Arbitrage SA, Citigroup Inc., Wolverine Trading LLC, IMC Chicago LLC, Gladius Capital Management LP, US Bancorp DE, Mint Tower Capital Management B.V., Clear Street Markets LLC, Cutler Group LP, XR Securities LLC, and Trinity Legacy Partners LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for AbbVie?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.77% of AbbVie's floating shares are currently sold short.

Is AbbVie's short interest increasing or decreasing?

AbbVie saw a increase in short interest during the month of August. As of August 31st, there was short interest totaling 13,550,000 shares, an increase of 3.5% from the previous total of 13,090,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is AbbVie's float size?

AbbVie currently has issued a total of 1,767,176,000 shares. Some of AbbVie's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. AbbVie currently has a public float of 1,760,000,000 shares.

How does AbbVie's short interest compare to its competitors?

0.77% of AbbVie's shares are currently sold short. Here is how the short interest of companies in the sub-industry of "pharmaceuticals" compare to AbbVie: Johnson & Johnson (0.00%), Pfizer Inc. (0.00%), Eli Lilly and Company (0.77%), Merck & Co., Inc. (0.00%), Bristol-Myers Squibb (0.92%), Zoetis Inc. (0.62%), Horizon Therapeutics Public Limited (1.85%), Royalty Pharma plc (1.80%), Jazz Pharmaceuticals plc (6.23%), and Perrigo Company plc (3.41%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Square, Inc. ($9.81 billion), S&P Global Inc. ($7.52 billion), Advanced Micro Devices, Inc. ($7.18 billion), Charter Communications, Inc. ($6.21 billion), Wayfair Inc. ($4.60 billion), Zoom Video Communications, Inc. ($3.23 billion), Uber Technologies, Inc. ($3.11 billion), Palo Alto Networks, Inc. ($2.74 billion), Teladoc Health, Inc. ($2.52 billion), and Etsy, Inc. ($2.16 billion). View all of the most shorted stocks.

What does it mean to sell short AbbVie stock?

Short selling ABBV is an investing strategy that aims to generate trading profit from AbbVie as its price is falling. AbbVie's stock is trading up $0.56 today. To short AbbVie stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that AbbVie will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against AbbVie?

A short squeeze for AbbVie occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ABBV, which in turn drives the price of the stock up even further.

How often is AbbVie's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ABBV, twice per month. The most recent reporting period available is August, 31 2021.

This page was last updated on 9/16/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.